Biospecialties Australia

Biospecialties Australia is a biotechnology company that specializes in the extraction and purification of high-value bioactive proteins from bovine milk. The company utilizes proprietary ion-exchange chromatography and membrane filtration technologies to produce high-purity Lactoferrin and Lactoperoxidase for the global pharmaceutical, nutraceutical, and infant formula markets. These proteins are recognized for their significant antimicrobial, anti-inflammatory, and immune-modulating properties. Founded to bridge the gap between dairy production and high-end biotechnology, the firm focuses on maintaining the biological activity of proteins during large-scale processing. In 2015, the company was acquired by Beston Global Food Company, which integrated the technology into its specialized nutritionals division. The company's production capabilities are centered on delivering pharmaceutical-grade dairy fractions that meet stringent international standards. Its technology platform is considered a leader in the efficient recovery of minor milk proteins from high-volume dairy streams.